These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1235 related items for PubMed ID: 11695354

  • 1. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 2. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
    Bochenek WJ, Mack ME, Fraga PD, Metz DC.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1105-14. PubMed ID: 15569113
    [Abstract] [Full Text] [Related]

  • 3. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
    Richter JE, Bochenek W.
    Am J Gastroenterol; 2000 Nov 15; 95(11):3071-80. PubMed ID: 11095320
    [Abstract] [Full Text] [Related]

  • 4. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S, Holtmann G.
    Clin Ther; 2010 Apr 15; 32(4):678-90. PubMed ID: 20435237
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO, Wilcox CM, DeVault K, Miska D, Bochenek W, Pantoprozole US Gerd Study Group B.
    Aliment Pharmacol Ther; 2002 Dec 15; 16(12):2043-52. PubMed ID: 12452936
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J, van Rensburg C, Vieweg W, Fischer R.
    Digestion; 2004 Dec 15; 70(1):61-9. PubMed ID: 15297779
    [Abstract] [Full Text] [Related]

  • 7. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL, Houcke P, Samoyeau R, French Collaborative Pantaprazole Study Group.
    Gastroenterol Clin Biol; 2001 Mar 15; 25(3):245-50. PubMed ID: 11395670
    [Abstract] [Full Text] [Related]

  • 8. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
    Labenz J, Armstrong D, Lauritsen K, Katelaris P, Schmidt S, Schütze K, Wallner G, Juergens H, Preiksaitis H, Keeling N, Nauclér E, Adler J, Eklund S.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):803-11. PubMed ID: 16225489
    [Abstract] [Full Text] [Related]

  • 9. Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole.
    Calleja JL, Suarez M, De Tejada AH, Navarro A, Pantogerd Group.
    Dig Dis Sci; 2005 Mar 01; 50(3):432-9. PubMed ID: 15810621
    [Abstract] [Full Text] [Related]

  • 10. Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine.
    Paré P, Armstrong D, Pericak D, Pyzyk M.
    J Clin Gastroenterol; 2003 Aug 01; 37(2):132-8. PubMed ID: 12869883
    [Abstract] [Full Text] [Related]

  • 11. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S, Dibildox M, Moguel A, Di Silvio M, Rodríguez F, Almaguer I, García C.
    Rev Gastroenterol Mex; 1998 Aug 01; 63(1):11-6. PubMed ID: 10068743
    [Abstract] [Full Text] [Related]

  • 12. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
    Holtmann G, Cain C, Malfertheiner P.
    Gastroenterology; 1999 Jul 01; 117(1):11-6. PubMed ID: 10381904
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
    van Zyl JH, de K Grundling H, van Rensburg CJ, Retief FJ, O'Keefe SJ, Theron I, Fischer R, Bethke T.
    Eur J Gastroenterol Hepatol; 2000 Feb 01; 12(2):197-202. PubMed ID: 10741935
    [Abstract] [Full Text] [Related]

  • 14. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F, Annese V, Prada A, Zambelli A, Casalini S, Nardini P, Bianchi Porro G, Italian Rabeprazole Study Group.
    Dig Liver Dis; 2005 Oct 01; 37(10):741-50. PubMed ID: 16024305
    [Abstract] [Full Text] [Related]

  • 15. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE, Fraga P, Mack M, Sabesin SM, Bochenek W, Pantoprazole US GERD Study Group.
    Aliment Pharmacol Ther; 2004 Sep 01; 20(5):567-75. PubMed ID: 15339328
    [Abstract] [Full Text] [Related]

  • 16. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T, Schütze K, van Leendert RJ, Fumagalli I, Costa Neves B, Bohuschke M, Gatz G.
    Digestion; 2003 Sep 01; 67(1-2):6-13. PubMed ID: 12743434
    [Abstract] [Full Text] [Related]

  • 17. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, Jennings DE.
    Am J Gastroenterol; 1993 Aug 01; 88(8):1212-7. PubMed ID: 8101695
    [Abstract] [Full Text] [Related]

  • 18. Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial.
    Madan K, Ahuja V, Kashyap PC, Sharma MP.
    Dis Esophagus; 2004 Aug 01; 17(4):274-8. PubMed ID: 15569362
    [Abstract] [Full Text] [Related]

  • 19. Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.
    Cloud ML, Offen WW, Robinson M.
    Am J Gastroenterol; 1991 Dec 01; 86(12):1735-42. PubMed ID: 1962618
    [Abstract] [Full Text] [Related]

  • 20. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
    Wo JM, Koopman J, Harrell SP, Parker K, Winstead W, Lentsch E.
    Am J Gastroenterol; 2006 Sep 01; 101(9):1972-8; quiz 2169. PubMed ID: 16968502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.